The use of triptans as an effective form of migraine treatment – review by Agata Borkowska, Anna Kiełb, Anna Mich, Anna Kaźmierczak, Patrycja Sornek, Wiktoria Izdebska, Igor Pawlak, Radosław Ciesielski, Jakub Stanek, Klaudia Perkowska

“… Introduction Migraine, a prevalent neurological disorder, is characterized by recurrent episodes of moderate to severe headache, often accompanied by symptoms such as nausea, photophobia, and phonophobia. Triptans, which belong to the class of serotonin 5-HT1B/1D receptor agonists, are integral to the management of migraine, providing prompt relief from symptoms. …”
Get full text

A Comprehensive Review of Celecoxib Oral Solution for the Acute Treatment of Migraine by Nazir Noor, Courtney LaChute, Mathew Root, Jasmine Rogers, Madeleine Richard, Giustino Varrassi, Ivan Urits, Omar Viswanath, Nazih Khater, Alan D. Kaye

“…A migraine is a clinical diagnosis with a presentation of one or more severe unilateral or bilateral headache(s) often preceded by an aura and typically accompanied by nausea, vomiting, photophobia, and/or phonophobia. This neurological disease is often debilitating and greatly affects the quality of life of those it inflicts. …”
Get full text

A Comprehensive Review of Zavegepant as Abortive Treatment for Migraine by Nazir Noor, Alexis Angelette, Abby Lawson, Anjana Patel, Ivan Urits, Omar Viswanath, Cyrus Yazdi, Alan D. Kaye

“…Migraine headache is a widespread and complex neurobiological disorder that is characterized by unilateral headaches that are often accompanied by photophobia and phonophobia. Migraine is one of the leading chief complaints in the emergency department with negative impacts on quality of life and activities of daily living. …”
Get full text

Eptinezumab-jjmr, a humanized monoclonal specific to Calcitonin Gene Related Peptide, for the preventive treatment of migraine in adults by Amnon A. Berger, Joseph Keefe, Cain W. Stark, Matthew Moore, Giovanni F. Ramírez, Julia R. Cucarola, Andrew H. Han, Alan D. Kaye, Latha Ganti

“…The pain is severe, often accompanied by co-morbid symptoms, such as photophobia, phonophobia, nausea and emesis, and is limiting in nature. …”
Get full text

Posterior Reversible Encephalopathy Syndrome as Presenting Form of Very Early Systemic Sclerosis by María Isabel Pedraza, Julia Barbado, Marina Ruiz, Ángel Luis Guerrero

“…A 64-year-old female was admitted due to 1-week pulsating headache more prominent on frontal scalp, accompanied by phonophobia, photophobia, and facial flushing. Neurological exam revealed brisk deep tendon reflex. …”
Get full text

THE ROLE OF ACUPUNCTURE THERAPY TO OVERCOME ONE-SIDE HEAD PAIN (MIGRAINE) by Mut Mainnah, Wurlina Wurlina, Maya Septriana

“…Background: Migraine is a primary headache, usually described as pain attacks lasting 4 - 72 hours, unilateral, throbbing, with moderate to severe pain intensity that can be exacerbated by activity, and can be accompanied by nausea and vomiting, photophobia and phonophobia. Migraine can interfere with patient activities, so that it can reduce productivity and result in an economic burden to the family and reduce the patient's quality of life. …”
Get full text

ACUPRESSURE AND AROMATIC GINGER HERB FOR A MIGRAINE by Mayla Khayra Al ‘Amali, Ario Imandiri, Sukardiman Sukardiman

“…Pain is usually unilateral, it is pulsating, the intensity of pain is moderate to severe and aggravated by activity, and can be accompanied by nausea, vomiting, photophobia, and phonophobia. Headaches are one of the most common disorders of the nervous system. …”
Get full text

Negative Emotions in Migraineurs Dreams: The Increased Prevalence of Oneiric Fear and Anguish, Unrelated to Mood Disorders by F. De Angeli, C. Lovati, L. Giani, C. Mariotti D'Alessandro, E. Raimondi, V. Scaglione, D. Castoldi, E. Capiluppi, C. Mariani

“…Migraineurs brain has shown some functional peculiarities that reflect not only in phonophobia, and photophobia, but also in mood and sleep. …”
Get full text

Reduction of pain and functional disability over time in patients treated with zavegepant: a post-hoc analysis of the BHV3500-301 phase 3 randomized controlled trial by Lauren Powell, Fiona O’Sullivan, Pramoda Jayasinghe, Basia Rogula, Feng Dai, Jessica Cirillo, Samantha Sweeney, Lucy Abraham, Jessica Ailani

“…In a regression model, treatment with zavegepant, lower pain severity, fewer baseline monthly migraine days, and absence of photophobia, phonophobia, and nausea were associated with better functioning (p < 0.05) over 48-h. …”
Get full text